Profilho is a treatment based on hyaluronic acid, a substance found naturally in the skin. It differs from traditional hyaluronic acid fillers in that it does not aim to add volume or fill specific wrinkles. Instead, Profilho focuses on deep hydration of the skin and stimulating collagen production.
The treatment consists of a series of injections in different areas of the face or body.
Once injected, Profilho spreads evenly under the skin, creating a hydrating and revitalizing effect.
Results may include improved skin elasticity, firmness and hydration, resulting in a smoother, more youthful appearance.
Profilho can be used to treat dehydrated or dull skin, lacking elasticity, especially on the face and neck.
Profilho can also be used to improve the skin’s quality around the décolleté, abdomen or limbs.
NCTF (New Cellular Treatment Factor), marketed by Fillmed Laboratories (Filorga), is a combination of nutrients, amino acids, vitamins and minerals. It is typically administered by injection into the skin to revitalize and rejuvenate. NCTF is designed to improve skin texture, reduce the appearance of fine lines and wrinkles, and restore radiance.
Several NCTF formulas are available to address different needs and areas of the face. Treatment is administered by qualified healthcare professionals who determine the appropriate formula and injection technique based on the patient’s individual needs.
NCTF is used to improve the quality of skin on the face, lower eyelids, neck and décolleté.
Wrinkled, desiccated and refined skin is a very good indication for Profilho or NCTF treatment.
It is important to consult with an experienced aesthetic physician to discuss your goals, concerns and expectations before deciding on the best treatment for your skin. These treatments can offer significant results, but it’s important to understand that results can vary.
61 Bd des Invalides, 75007 Paris
Since setting up my own business, I have spent 4 years taking additional university courses focusing on aesthetic and restorative medicine.